LEXI - AI Legal Assistant
Sorry, there was an error communicating with our API.
Try refreshing the page, and if the error persists, please try again in a few minutes.
Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)
2009/2/EC • 32009L0002
Legal Acts - L
- Inbound citations: 26
- •
- Cited paragraphs: 0
- •
- Outbound citations: 10
Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)
2009/2/EC • 32009L0002
Legal Acts - L
Cited paragraphs only
16.1.2009
EN
Official Journal of the European Union
L 11/6
COMMISSION DIRECTIVE 2009/2/EC
of 15 January 2009
amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (1), and in particular Article 28 thereof,
Whereas:
(1)
Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.
(2)
Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.
(3)
Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.
(4)
Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.
(5)
Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.
(6)
The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.
(7)
As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.
(8)
The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.
(9)
The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,
HAS ADOPTED THIS DIRECTIVE:
Article 1
Directive 67/548/EEC is amended as follows. Annex I is amended as follows:
(a)
the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;
(b)
the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;
(c)
the entries set out in Annex 1C to this Directive are deleted.
Article 2
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Article 3
This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Article 4
This Directive is addressed to the Member States.
Done at Brussels, 15 January 2009.
For the Commission
Stavros DIMAS
Member of the Commission
(1) OJ 196, 16.8.1967, p. 1.
ANNEX 1A
Index No
Chemical name
Notes related to substances
EC No
CAS No
Classification
Labelling
Concentration Limits
Notes related to preparations
001-002-00-4
aluminium lithium hydride
240-877-9
16853-85-3
F; R15
C; R35
F; C
R: 15-35
S: (1/2-)7/8-26-36/37/39-43-45
005-006-00-7
dibutyltin hydrogen borate
E
401-040-5
75113-37-0
Muta. Cat. 3; R68
Repr. Cat. 2; R60-61
T; R48/25
Xn; R21/22
Xi; R41
R43
N; R50-53
T; N
R: 60-61-21/22-41-43-48/25-68-50/53
S: 53-45-60-61
006-007-00-5
salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex
A
—
—
T+; R26/27/28
R32
N; R50-53
T+; N
R: 26/27/28-32-50/53
S: (1/2-)7-28-29-45-60-61
006-015-00-9
diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4
330-54-1
Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-40-48/22-50/53
S: (2-)13-36/37-46-60-61
C ≥ 25 %: Xn, N; R22-40-48/22-50/53
10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53
2,5 % ≤ C < 10 %: Xn, N; R40-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
006-076-00-1
mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
—
8018-01-7
Repr. Cat. 3; R63
R43
N; R50
Xn; N
R: 43-63-50
S: (2-)36/37-46-61
C ≥ 5 %: Xn, N; R43-63-50
2,5 ≤ C < 5 %: Xi, N; R43-50
1 % ≤ C < 2,5 %: Xi; R43
006-077-00-7
maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric)
235-654-8
12427-38-2
Repr. Cat. 3; R63
Xn; R20
Xi; R36
R43
N; R50-53
Xn; N
R: 20-36-43-63-50/53
S: (2-)36/37-46-60-61
C ≥ 25 %: Xn, N; R20-36-43-63-50/53
20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53
5 % ≤ C < 20 %: Xn, N; R43-63-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
006-084-00-5
carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate
259-565-9
55285-14-8
T+; R26
T; R25
R43
N; R50-53
T+; N
R: 25-26-43-50/53
S: (1/2-)28-36/37-38-45-63-60-61
006-088-00-7
benfuracarb (ISO);
ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate
—
82560-54-1
Repr. Cat. 3; R62
T; R23
Xn; R22
N; R50-53
T; N
R: 22-23-62-50/53
S: (1/2-)36/37-45-60-61
007-002-00-0
nitrogen dioxide; [1]
dinitrogen tetraoxide [2]
233-272-6 [1]
234-126-4 [2]
10102-44-0 [1]
10544-72-6 [2]
O; R8
T+; R26
C; R34
O; T+
R: 8-26-34
S: (1/2-)9-26-28-36/37/39-45
C ≥ 10 %: T+; R26-34
5 % ≤ C < 10 %: T; R23-34
1 % ≤ C < 5 %: T; R23-36/37/38
0,5 % ≤ C < 1 %: Xn; R20-36/37/38
0,1 % ≤ C < 0,5 %: Xn; R20
5
015-041-00-X
malathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]
204-497-7
121-75-5
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-46-60-61
C ≥ 25 %: Xn, N; R22-43-50/53
1 % ≤ C < 25 %: Xi, N; R43-50/53
0,025 % ≤ C < 1 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
015-100-00-X
phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-3
14816-18-3
Repr. Cat. 3; R62
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-62-50/53
S: (2-)36/37-46-60-61
C ≥ 25 %: Xn, N; R22-43-62-50/53
5 % ≤ C < 25 %: Xn, N; R43-62-50/53
1 % ≤ C < 5 %: Xi, N; R43-50/53
0,025 % ≤ C < 1 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
015-102-00-0
tris(2-chloroethyl)phosphate
E
204-118-5
115-96-8
Carc. Cat. 3; R40
Repr. Cat. 2; R60
Xn; R22
N; R51-53
T; N
R: 60-22-40-51/53
S: 53-45-61
015-155-00-X
glufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate
E
278-636-5
77182-82-2
Repr. Cat. 2; R60
Repr. Cat. 3; R63
Xn; R20/21/22-48/20/22
T
R: 60-20/21/22-48/20/22-63
S: 53-45
016-009-00-8
disodium sulfide;
sodium sulfide
215-211-5
1313-82-2
T; R24
Xn; R22
C; R34
R31
N; R50
T; C; N
R: 22-24-31-34-50
S: (1/2-)26-36/37/39-45-61
017-009-00-0
ammonium perchlorate;
[containing ≥ 80 % of 0-30 μm particles]
T
232-235-1
7790-98-9
E; R3
O; R9
E
R: 3-9
S: (2-)14-16-36/37
024-004-00-7
sodium dichromate
E
234-190-3
10588-01-9
O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53
O; T+; N
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61
C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53
10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53
7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53
5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53
3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53
2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53
1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53
0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53
0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53
0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43
0,1 % ≤ C < 0,2 %: T; R45-46-20
3
027-002-00-4
cobalt oxide
215-154-6
1307-96-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
C ≥ 25 %: Xn, N; R22-43-50/53
2,5 % ≤ C < 25 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
027-003-00-X
cobalt sulfide
215-273-3
1317-42-6
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61
C ≥ 2,5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
028-003-00-2
nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]
E
215-215-7 [1]
234-323-5 [2]
- [3]
1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]
Carc. Cat. 1; R49
T; R48/23
R43
R53
T
R: 49-43-48/23-53
S: 53-45-61
028-004-00-8
nickel dioxide
E
234-823-3
12035-36-8
Carc. Cat. 1; R49
T; R48/23
R43
R53
T
R: 49-43-48/23-53
S: 53-45-61
028-005-00-3
dinickel trioxide
E
215-217-8
1314-06-3
Carc. Cat. 1; R49
T; R48/23
R43
R53
T
R: 49-43-48/23-53
S: 53-45-61
028-006-00-9
nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]
E
240-841-2 [1]
234-349-7 [2]
- [3]
16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61
028-007-00-4
trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]
E
234-829-6 [1]
- [2]
12035-72-2 [1]
12035-71-1 [2]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61
028-008-00-X
nickel dihydroxide; [1]
nickel hydroxide [2]
E
235-008-5 [1]
234-348-1 [2]
12054-48-7 [1]
11113-74-9 [2]
Carc. Cat. 1; R49
Repr. Cat. 2; R61
Muta. Cat. 3; R68
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61
029-013-00-X
trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)
407-580-8
130201-51-3
Xi; R41
Xi
R: 41
S: (2-)26-39
033-005-00-1
arsenic acid and its salts with the exception of those specified elsewhere in this Annex
AE
—
—
Carc. Cat. 1; R45
T; R23/25
N; R50-53
T; N
R: 45-23/25-50/53
S: 53-45-60-61
034-002-00-8
selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex
A
—
—
T; R23/25
R33
N; R50-53
T; N
R: 23/25-33-50/53
S: (1/2-)20/21-28-45-60-61
047-001-00-2
silver nitrate
231-853-9
7761-88-8
O; R8
C; R34
N; R50-53
O; C; N
R: 8-34-50/53
S: (1/2-)26-36/37/39-45-60-61
050-002-00-0
cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide
236-049-1
13121-70-5
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61
C ≥ 25 %: Xn, N; R20/21/22-50/53
0,025 % ≤ C < 25 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
050-003-00-6
fentin acetate (ISO);
triphenyltin acetate
212-984-0
900-95-8
Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53
T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61
C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
0,25 % ≤ C < 1 %: Xn, N; R20-51/53
0,1 % ≤ C < 0,25 %: Xn; R20-52/53
0,025 % ≤ C < 0,1 %: R52/53
050-004-00-1
fentin hydroxide (ISO);
triphenyltin hydroxide
200-990-6
76-87-9
Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53
T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61
C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
0,25 % ≤ C < 1 %: Xn, N; R20-51/53
0,1 % ≤ C < 0,25 %: Xn; R20-52/53
0,025 % ≤ C < 0,1 %: R52/53
050-008-00-3
tributyltin compounds, with the exception of those specified elsewhere in this Annex
A
—
—
T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53
T; N
R: 21-25-36/38-48/23/25-50/53
S: (1/2-)36/37/39-45-60-61
C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53
1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53
0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53
0,025 % C < 0,25 %: R52/53
1
050-011-00-X
triphenyltin compounds, with the exception of those specified elsewhere in this Annex
A
—
—
T; R23/24/25
N; R50-53
T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61
C ≥ 1 %: T, N; R23/24/25-50/53
0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53
1
050-018-00-8
tin(II) methanesulphonate
401-640-7
53408-94-9
C; R34
Xn; R22
R43
N; R51-53
C; N
R: 22-34-43-51/53
S: (1/2-)22-26-36/37/39-45-61
053-003-00-4
iodoxybenzene
—
696-33-3
E; R2
E
R: 2
S: (2-)35
053-004-00-X
calcium iodoxybenzoate
C
—
—
E; R2
E
R: 2
S: (2-)35
080-001-00-0
mercury
E
231-106-7
7439-97-6
Repr. Cat. 2; R61
T+; R26
T; R48/23
N; R50-53
T+; N
R: 61-26-48/23-50/53
S: 53-45-60-61
080-010-00-X
mercury dichloride;
mercuric chloride
231-299-8
7487-94-7
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T+; R28
T; R48/24/25
C; R34
N; R50-53
T+; N
R: 28-34-48/24/25-62-68-50/53
S: (1/2-)26-36/37/39-45-60-61
092-002-00-3
uranium compounds with the exception of those specified elsewhere in this Annex
A
—
—
T+; R26/28
R33
N; R51-53
T+; N
R: 26/28-33-51/53
S: (1/2-)20/21-45-61
601-065-00-3
A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);
(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)
416-930-9
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)36/37-61
602-007-00-X
bromoform;
tribromomethane
200-854-6
75-25-2
T; R23
Xn; R22
Xi; R36/38
N; R51-53
T; N
R: 22-23-36/38-51/53
S: (1/2-)28-45-63-61
602-030-00-5
1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2]
C D
208-826-5 [1]
233-195-8 [2]
542-75-6 [1]
10061-01-5 [2]
R10
T; R24/25
Xn; R20-65
Xi; R36/37/38
R43
N; R50-53
T; N
R: 10-20-24/25-36/37/38-43-65-50/53
S: (1/2-)36/37-45-60-61
602-054-00-6
3-iodpropene;
allyl iodide
209-130-4
556-56-9
F; R11
C; R34
F; C
R: 11-34
S: (1/2-)7-16-26-45
603-005-00-1
2-methylpropan-2-ol;
tert-butyl alcohol
200-889-7
75-65-0
F; R11
Xn; R20
Xi; R36/37
F; Xn
R: 11-20-36/37
S: (2-)9-16-46
603-018-00-2
furfuryl alcohol
202-626-1
98-00-0
Carc. Cat. 3; R40
T; R23
Xn; R21/22-48/20
Xi; R36/37
T
R: 21/22-23-36/37-40-48/20
S: (1/2-)36/37-45-63
603-023-00-X
ethylene oxide;
oxirane
E
200-849-9
75-21-8
F+; R12
R6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T; R23
Xi; R36/37/38
F+; T
R: 45-46-6-12-23-36/37/38
S: 53-45
603-029-00-2
bis(2-chloroethyl) ether
203-870-1
111-44-4
Carc. Cat. 3; R40
T+; R26/27/28
T+
R: 26/27/28-40
S: (1/2-)7/9-27-28-36/37-45
C ≥ 7 %: T+; R26/27/28-40
1 % ≤ C < 7 %: T; R23/24/25-40
0,1 % ≤ C < 1 %: Xn; R20/21/22
603-037-00-6
cellulose nitrate;
nitrocellulose
T
—
—
E; R3
E
R: 3
S: (2-)35
603-046-00-5
bis(chloromethyl) ether;
oxybis(chloromethane)
E
208-832-8
542-88-1
F; R11
Carc. Cat. 1; R45
T+; R26
T; R24
Xn; R22
F; T+
R: 45-11-22-24-26
S: 53-45
C ≥ 25 %: T+; R45-22-24-26
7 % ≤ C < 25 %: T+; R45-21-26
3 % ≤ C < 7 %: T; R45-21-23
1 % ≤ C < 3 %: T; R45-23
0,1 % ≤ C < 1 %: T; R45-20
0,001 % ≤ C < 0,1 %: T; R45
603-064-00-3
1-methoxy-2-propanol;
monopropylene glycol methyl ether
203-539-1
107-98-2
R10
R67
R: 10-67
S: (2-)
603-066-00-4
1,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide
203-437-7
106-87-6
Carc. Cat. 3; R40
T; R23/24/25
T
R: 23/24/25-40
S: (1/2-)36/37-45-63
C ≥ 1 %: T; R23/24/25-40
0,1 % ≤ C < 1 %: Xn; R20/21/22
605-004-00-1
2,4,6-trimethyl-1,3,5-trioxane;
paraldehyde
204-639-8
123-63-7
R10
R: 10
S: (2-)29
605-005-00-7
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde
203-600-2
108-62-3
F; R11
Xn; R22
F; Xn
R: 11-22
S: (2-)13-16-25-46
606-021-00-7
N-methyl-2-pyrrolidone;
1-methyl-2-pyrrolidone
212-828-1
872-50-4
Repr. Cat. 2; R61
Xi; R36/37/38
T
R: 61-36/37/38
S: 53-45
C ≥ 10 %: T; R61-36/37/38
5 % ≤ C < 10 %: T; R61
607-007-00-3
salts of oxalic acid with the exception of those specified elsewhere in this Annex
A
—
—
Xn; R21/22
Xn
R: 21/22
S: (2-)24/25
C ≥ 5 %: Xn; R21/22
607-012-00-0
benzoyl chloride
202-710-8
98-88-4
Xn; R20/21/22
C; R34
R43
C
R: 20/21/22-34-43
S: (1/2-)26-36/37/39-45
607-037-00-7
2-ethoxyethyl acetate;
ethylglycol acetate
E
203-839-2
111-15-9
R10
Repr. Cat. 2; R60-61
Xn; R20/21/22
T
R: 60-61-10-20/21/22
S: 53-45
607-051-00-3
MCPA (ISO);
4-chloro-o-tolyloxyacetic acid
202-360-6
94-74-6
Xn; R22
Xi; R38-41
N; R50-53
Xn; N
R: 22-38-41-50/53
S: (2-)26-37-39-60-61
607-052-00-9
salts and esters of MCPA
A
—
—
Xn; R20/21/22
N; R50-53
Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61
607-085-00-9
benzyl benzoate
204-402-9
120-51-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)25-46-61
607-095-00-3
maleic acid
203-742-5
110-16-7
Xn; R22
Xi; R36/37/38
R43
Xn
R: 22-36/37/38-43
S: (2-)24-26-28-37-46
C ≥ 25 %: Xn; R22-36/37/38-43
20 % ≤ C <25 %: Xi; R36/37/38-43
0,1 % ≤ C < 20 %: Xi; R43
607-103-00-5
succinic anhydride
203-570-0
108-30-5
Xn; R22
Xi; R36/37
Xn
R: 22-36/37
S: (2-)25-46
C ≥ 5 %: Xn; R22-36/37
1 % ≤ C < 5 %: Xi; R36/37
607-142-00-8
propyl chloroformate;
chloroformic acid propylester;
n-propyl chloroformate
203-687-7
109-61-5
F; R11
T; R23
C; R34
F; T
R: 11-23-34
S: (1/2-)16-26-36-45
607-195-00-7
2-methoxy-1-methylethyl acetate
203-603-9
108-65-6
R10
R: 10
S: (2-)
607-216-00-X
glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine
403-950-8
—
T+; R26
Xn; R22
C; R34
N; R50
T+; N
R: 22-26-34-50
S: (1/2-)26-36/37/39-38-45-61
607-231-00-1
clopyralid (ISO);
3,6-dichloropyridine-2-carboxylic acid
216-935-4
1702-17-6
Xi; R41
Xi
R: 41
S: (2-)26-39
607-245-00-8
tert-butyl acrylate
D
216-768-7
1663-39-4
F; R11
Xn; R20/21/22
Xi; R37/38
R43
N; R51-53
F; Xn; N
R: 11-20/21/22-37/38-43-51/53
S: (2-)16-25-37-61
C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53
20 % ≤ C < 25 %: Xi; R37/38-43-52/53
2,5 % ≤ C < 20 %: Xi; R43-52/53
1 % ≤ C < 2,5 %: Xi; R43
607-397-00-5
A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);
Ca phenates (branched C10-14 and C18-30 alkylated);
Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)
415-930-6
—
Repr. Cat. 3; R62
R43
Xn
R: 43-62
S: (2-)23-36/37
608-005-00-5
n-butyronitrile
203-700-6
109-74-0
F; R11
T; R23/24/25
F; T
R: 11-23/24/25
S: (1/2-)16-36/37-45-63
608-011-00-8
oxalonitrile;
cyanogen
207-306-5
460-19-5
F+; R12
T; R23
N; R50-53
F+; T; N
R: 12-23-50/53
S: (1/2-)9-16-23-33-45-63-60-61
608-044-00-8
2-cyclohexylidene-2-phenylacetonitrile
423-740-1
10461-98-0
Xn; R22
N; R51-53
Xn; N
R; 22-51/53
S: (2-)46-61
609-007-00-9
2,4-dinitrotoluene; [1]
dinitrotoluene [2]
E
204-450-0 [1]
246-836-1 [2]
121-14-2 [1]
25321-14-6 [2]
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R50-53
T; N
R: 45-23/24/25-48/22-62-68-50/53
S: 53-45-60-61
611-028-00-3
C,C′-azodi(formamide)
204-650-8
123-77-3
E; R2
R42
E; Xn
R: 2-42
S: (2-)22-24-37
611-035-00-1
tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate
403-660-1
107246-80-0
N; R51-53
N
R: 51/53
S: 61
612-044-00-3
N,N′-diacetylbenzidine
E
210-338-2
613-35-4
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/21/22
T
R: 45-20/21/22-68
S: 53-45
612-050-00-6
cyclohexylamine
203-629-0
108-91-8
R10
Repr. Cat. 3; R62
Xn; R21/22
C; R34
C
R: 10-21/22-34-62
S: (1/2-)26-36/37/39-45
C ≥ 25 %: C; R21/22-34-62
10 % ≤ C < 25 %: C; R34-62
5 % ≤ C < 10 %: Xn; R36/38-62
2 % ≤ C < 5 %: Xi; R36/38
612-076-00-8
ethyldimethylamine
209-940-8
598-56-1
F; R11
Xn; R20/22
C; R34
F; C
R: 11-20/22-34
S: (1/2-)3-16-26-36-45
612-099-00-3
4-methyl-m-phenylenediamine;
2,4-toluenediamine
E
202-453-1
95-80-7
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
R43
N; R51-53
T; N
R: 45-21-25-43-48/22-62-68-51/53
S: 53-45-61
612-101-00-2
methenamine;
hexamethylenetetramine
202-905-8
100-97-0
F; R11
R43
F; Xi
R: 11-43
S: (2-)24-37
612-151-00-5
methyl-phenylene diamine;
diaminotoluene;
[technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]
E
—
—
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
Xi; R36
R43
N; R51-53
T; N
R: 45-21-25-36-43-48/22-62-68-51/53
S: 53-45-61
612-237-00-2
hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]
T
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
E; R2
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R36/38
R43
N; R50
E; Xn; N
R: 21/22-36/38-40-43-48/22-50
S: (2-)36/37-61
613-116-00-7
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
T+; R26
T; R48/23
Xi; R36/37/38
R43
N; R50
T+; N
R: 26-36/37/38-43-48/23-50
S: (1/2-)28-36/37/39-45-63-61
C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50
10 % ≤ C < 20 %: T+, N; R26-43-48/23-50
7 % ≤ C < 10 %: T+, N; R26-43-48/20-50
2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50
1 % ≤ C < 2,5 %: T; R23-43-48/20
0,1 % ≤ C < 1 %: Xn; R20
615-001-00-7
methyl isocyanate
210-866-3
624-83-9
F; R11
Repr. Cat. 3; R63
T+; R26
T; R24/25
R42/43
Xi; R37/38-41
F; T+
R: 11-24/25-26-37/38-41-42/43-63
S: (1/2-)16-26-27/28-36/37/39-45-63
615-004-00-3
salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
A
—
—
Xn; R20/21/22
R32
R52-53
Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61
615-028-00-4
ethyl 2-(isocyanatosulfonyl)benzoate
410-220-2
77375-79-2
R14
Xn; R22-48/22
Xi; R41
R42/43
Xn
R: 14-22-41-42/43-48/22
S: (2-)8-23-26-30-35-36/37/39
615-030-00-5
alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
A
—
—
Xn; R20/21/22
R32
R52-53
Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61
615-031-00-0
thallium thiocyanate
222-571-7
3535-84-0
T+; R26/28
Xn; R21
R32
R33
N; R51-53
T+; N
R: 21-26/28-32-33-51/53
S: (1/2-)13-28-36/37-45-61
615-032-00-6
metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
A
—
—
Xn; R20/21/22
R32
N; R50-53
Xn; N
R: 20/21/22-32-50/53
S: (2-)13-36/37-46-60-61
616-124-00-9
lithium bis(trifluoromethylsulfonyl)imide
415-300-0
90076-65-6
T; R24/25
Xn; R48/22
C; R34
R52-53
T
R: 24/25-34-48/22-52/53
S: (1/2-)22-26-36/37/39-45-61
617-017-00-X
A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene
T
412-140-3
32144-25-5
E; R2
O; R7
R53
E
R: 2-7-53
S: (2-)3/7-14-36/37/39-61
650-016-00-2
Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]
AQR
—
—
Carc. Cat. 3; R40
Xn
R: 40
S: (2-)36/37
650-017-00-8
Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]
AR
—
—
Carc. Cat. 2; R49
T
R: 49
S: 53-45
ANNEX 1B
Index No
Chemical name
Notes related to substances
EC No
CAS No
Classification
Labelling
Concentration Limits
Notes related to preparations
003-003-00-5
(2-methylpropyl)lithium;
isobutyllithium
440-620-2
920-36-5
F; R15-17
R14
C; R35
R67
N; R50-53
F; C; N
R: 14/15-17-35-67-50/53
S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61
005-013-00-5
diethylmethoxyborane
425-380-9
7397-46-8
F; R17
Xn; R20/21/22-48/22
C; R34
R43
R53
F; C
R: 17-20/21/22-34-43-48/22-53
S: (1/2-)6-26-36/37/39-43-45-61
005-014-00-0
4-formylphenylboronic acid
438-670-5
87199-17-5
R43
Xi
R: 43
S: (2-)24-37
005-017-00-7
sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
E
239-172-9 [1]
234-390-0 [2]
- [3]
231-556-4 [4]
- [5]
15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5]
O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R22
Xi; R37-41
O; T
R: 61-8-22-37-41-62
S: 53-45
C ≥ 25 %: T; R61-22-37-41-62
22 % ≤ C < 25 %: T; R61-37-41-62
20 % ≤ C < 22 %: T; R61-36/37-62
14 % ≤ C < 20 %: T; R61-36-62
9 % ≤ C < 14 %: T; R61-62
6,5 % ≤ C < 9 %: T; R61
005-017-01-4
sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
E
239-172-9 [1]
234-390-0 [2]
- [3]
231-556-4 [4]
- [5]
15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5]
O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T; R23
Xn; R22
Xi; R37-41
O; T
R: 61-8-22-23-37-41-62
S: 53-45
C ≥ 25 %: T; R61-22-23-37-41-62
22 % ≤ C < 25 %: T; R61-20-37-41-62
20 % ≤ C < 22 %: T; R61-20-36/37-62
14 % ≤ C < 20 %: T; R61-20-36-62
9 % ≤ C < 14 %: T; R61-20-62
6,5 % ≤ C < 9 %: T; R61-20
3 % ≤ C < 6,5 %: Xn; R20
005-018-00-2
perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
- [1]
- [2]
- [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R37-41
T
R: 61-37-41-62
S: 53-45-47
C ≥ 36 %: T; R61-37-41-62
22 % ≤ C < 36 %: T; R61-36/37-62
20 % ≤ C < 22 %: T; R61-37-62
14 % ≤ C < 20 %: T; R61-62
10 % ≤ C < 14 %: T; R61
005-018-01-X
perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
E
- [1]
- [2]
- [3]
13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R20
Xi; R37-41
T
R: 61-20-37-41-62
S: 53-45-47
C ≥ 36 %: T; R61-20-37-41-62
25 % ≤ C < 36 %: T; R61-20-36/37-62
22 % ≤ C < 25 %: T; R61-36/37-62
20 % ≤ C < 22 %: T; R61-37-62
14 % ≤ C < 20 %: T; R61-62
10 % ≤ C < 14 %: T; R61
006-097-00-6
1-phenyl-3-(p-toluenesulfonyl)urea
424-620-1
13909-63-2
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)22-36-61
006-098-00-1
tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate
429-170-8
134575-17-0
Xn; R22-48/22
Xi; R41
R43
Xn
R: 22-41-43-48/22
S: (2-)22-26-36/37/39
006-099-00-7
N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate
432-520-2
232938-43-1
N; R51-53
N
R: 51/53
S: 22-61
006-101-00-6
mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;
N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]
423-070-8
—
R53
R: 53
S: 61
006-102-00-1
O-hexyl-N-ethoxycarbonylthiocarbamate
E
432-750-3
—
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22-48/22
R43
N; R51-53
T; N
R: 45-46-22-43-48/22-51/53
S: 53-45-61
006-103-00-7
N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea
445-760-8
—
Xi; R41
R42
N; R50-53
Xn; N
R: 41-42-50/53
S: (2-)22-26-39-45-60-61
C ≥10 %: Xn, N; R41-42-50/53
5 % ≤ C < 10 %: Xn, N; R36-42-50/53
1 % ≤ C < 5 %: Xn, N; R42-50/53
0,25 % ≤ C < 1 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 ≤ C < 0,025 %: R52/53
007-029-00-8
diethyldimethylammonium hydroxide
419-400-5
95500-19-9
Xn; R21/22
C; R35
C
R: 21/22-35
S: (1/2-)26-36/37/39-45
012-004-00-X
aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate
422-150-1
—
N; R50-53
N
R: 50/53
S: 60-61
014-036-00-X
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane
405-020-7
105024-66-6
Repr.Cat.2; R60
N; R50-53
T; N
R: 60-50/53
S: 53-45-60-61
C ≥ 0,5 %: T, N; R60-50/53
0,025 % ≤ C < 0,5 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
014-037-00-5
2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime
433-360-6
34036-80-1
Xn; R48/22
R43
R52-53
Xn
R: 43-48/22-52/53
S: (2-)36/37-61
014-038-00-0
S-(3-(triethoxysilyl)propyl)octanethioate
436-690-9
220727-26-4
R43
Xi
R: 43
S: (2-)24-37
014-039-00-6
(2,3-dimethylbut-2-yl)-trimethoxysilane
439-360-2
142877-45-0
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-37/39-61
014-041-00-7
N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane
445-890-5
201290-01-9
Xn; R22
R43
Xn
R: 22-43
S: (2-)24-37
014-042-00-2
mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)
423-010-0
—
Xi; R41
Xi
R: 41
S: (2-)26-39
014-043-00-8
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)
432-200-2
—
F; R11
Xi; R37/38-41
R52-53
F; Xi
R: 11-37/38-41-52/53
S: (2-)6-26-36/39-61
014-044-00-3
3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane
433-050-0
—
N; R51-53
N
R: 51/53
S: 61
014-045-00-9
magnesium sodium fluoride silicate
442-650-1
—
Xn; R48/20
Xn
R: 48/20
S: (2-)22-36
015-190-00-0
bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
421-920-2
154862-43-8
R53
R: 53
S: 61
015-191-00-6
dodecyldiphenyl phosphate
431-760-5
27460-02-2
Xi; R38
R52-53
Xi
R: 38-52/53
S: (2-)37-61
015-192-00-1
tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate
432-770-2
139189-30-3
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
015-193-00-7
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)
442-960-7
332350-93-3
T; R25
Xi; R41
N; R50-53
T; N
R: 25-41-50/53
S: (1/2-)26-39-45-60-61
015-194-00-2
tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate
444-440-5
220689-12-3
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61
015-195-00-8
mixture of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate;
potassium p-toluenephosphonate
433-860-4
—
Xi; R36
R43
R52-53
Xi
R: 36-43-52/53
S: (2-)24-26-37-61
015-196-00-3
mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
435-960-3
—
Carc.Cat.2; R45
Muta.Cat.2; R46
R43
T
R: 45-46-43
S: 53-45
015-197-00-9
bis(2,4,4-trimethylpentyl)dithiophosphonic acid
420-160-9
107667-02-7
R10
T; R23
Xn; R22
C; R34
N; R51-53
T; N
R: 10-22-23-34-51/53
S: (1/2-)9-26-36/37/39-45-61
015-198-00-4
(4-phenylbutyl)phosphinic acid
420-450-5
86552-32-1
Carc.Cat.3; R40
Xi; R41
Xn
R: 40-41
S: (2-)23-26-36/37/39
016-094-00-1
sulfur
231-722-6
7704-34-9
Xi; R38
Xi
R: 38
S: (2-)46
016-097-00-8
1-amino-2-methyl-2-propanethiol hydrochloride
434-480-1
32047-53-3
Xn; R22
C; R34
R43
R52-53
C
R: 22-34-43-52/53
S: (1/2-)22-26-36/37/39-45-61
017-009-01-8
ammonium perchlorate;
[containing < 80 % of 0-30 μm particles]
T
232-235-1
7790-98-9
E; R2
O; R9
E
R: 2-9
S: (2-)14-16-36/37
022-004-00-1
potassium titanium oxide (K2Ti6O13)
432-240-0
12056-51-8
Carc.Cat.3; R40
Xn
R: 40
S: (2-)22-36/37
022-005-00-7
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium
419-840-8
169104-71-6
F; R11
C; R34
R43
R53
F; C
R: 11-34-43-53
S: (1/2-)6-9-16-26-36/37/39-45-61
028-002-01-4
nickel powder;
[particle diameter < 1 mm]
231-111-4
7440-02-0
Carc. Cat. 3; R40
T; R48/23
R43
R52-53
T
R: 40-43-48/23-52/53
S: (2-)36/37/39-45-61
028-013-00-7
nickel matte
E, H
273-749-6
69012-50-6
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-014-00-2
slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate
E
295-859-3
92129-57-2
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53
T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53
20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53
2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-015-00-8
slimes and sludges, copper electrolyte refining, decopperised
E, H
305-433-1
94551-87-8
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-62-68-50/53
S: 53-45-60-61
028-016-00-3
nickel diperchlorate;
perchloric acid, nickel(II) salt
E, H
237-124-1
13637-71-3
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
C; R34
R42/43
N; R50-53
T; N
R: 49-61-34-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53
5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53
2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-017-00-9
nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]
E, H
237-563-9 [1]
239-793-2 [2]
13842-46-1 [1]
15699-18-0 [2]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53
T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-018-00-4
nickel bis(sulfamidate);
nickel sulfamate
E, H
237-396-1
13770-89-3
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-019-00-X
nickel bis(tetrafluoroborate)
E, H
238-753-4
14708-14-6
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-021-00-0
nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]
E, H
222-101-0 [1]
239-946-6 [2]
268-755-0 [3]
3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C 0,1 %: Xi; R43
028-022-00-6
nickel di(acetate); [1]
nickel acetate [2]
E, H
206-761-7 [1]
239-086-1 [2]
373-02-4 [1]
14998-37-9 [2]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53
T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-024-00-7
nickel dibenzoate
E, H
209-046-8
553-71-9
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-025-00-2
nickel bis(4-cyclohexylbutyrate)
E, H
223-463-2
3906-55-6
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-026-00-8
nickel(II) stearate;
nickel(II) octadecanoate
E, H
218-744-1
2223-95-2
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-027-00-3
nickel dilactate
E, H
—
16039-61-5
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-028-00-9
nickel(II) octanoate
E, H
225-656-7
4995-91-9
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat 2; R61
T; R48/23
C; R35
R42/43
N; R50-53
T; C; N
R: 49-61-35-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53
10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53
5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53
2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-029-00-4
nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]
E, H
233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]
10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-030-00-X
nickel hexafluorosilicate
E, H
247-430-7
26043-11-8
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-031-00-5
nickel selenate
E, H
239-125-2
15060-62-5
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-032-00-0
nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]
E, H
238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]
14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-033-00-6
diammonium nickel hexacyanoferrate
E, H
—
74195-78-1
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-034-00-1
nickel dicyanide
E, H
209-160-8
557-19-7
Carc. Cat. 1; R49
T; R48/23
R42/43
R32
N; R50-53
T; N
R: 49-32-42/43-48/23-50/53
S: 53-45-60-61
028-035-00-7
nickel chromate
E, H
238-766-5
14721-18-7
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-036-00-2
nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
E, H
244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]
21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-037-00-8
dinickel hexacyanoferrate
E, H
238-946-3
14874-78-3
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-038-00-3
trinickel bis(arsenate);
nickel(II) arsenate
E, H
236-771-7
13477-70-8
Carc. Cat. 1; R45
T; R48/23
R43
N; R50-53
T; N
R: 45-43-48/23-50/53
S: 53-45-60-61
028-039-00-9
nickel oxalate; [1]
oxalic acid, nickel salt [2]
E, H
208-933-7 [1]
243-867-2 [2]
547-67-1 [1]
20543-06-0 [2]
Carc. Cat. 1; R49
T; R48/23
R43
N: R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-040-00-4
nickel telluride
E, H
235-260-6
12142-88-0
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-041-00-X
trinickel tetrasulfide
E, H
—
12137-12-1
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-042-00-5
trinickel bis(arsenite)
E, H
—
74646-29-0
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-043-00-0
cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]
E, H
269-051-6 [1]
261-346-8 [2]
- [3]
68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45
028-044-00-6
nickel tin trioxide;
nickel stannate
E, H
234-824-9
12035-38-0
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45
028-045-00-1
nickel triuranium decaoxide
E, H
239-876-6
15780-33-3
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45
028-046-00-7
nickel dithiocyanate
E, H
237-205-1
13689-92-4
Carc. Cat. 1; R49
Muta. Cat. 3;R68
Repr. Cat. 2; R61
T; R48/23
R42/43
R32
N; R50-53
T; N
R: 49-61-32-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-047-00-2
nickel dichromate
E, H
239-646-5
15586-38-6
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1% ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C 0,1 %: Xi; R43
028-048-00-8
nickel(II) selenite
E, H
233-263-7
10101-96-9
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-049-00-3
nickel selenide
E, H
215-216-2
1314-05-2
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-050-00-9
silicic acid, lead nickel salt
E, H
—
68130-19-8
Carc. Cat. 1: R49
Repr. Cat. 1: R61
Repr. Cat. 3; R62
T; R48/23
R43
N; R50-53
T; N
R: 49-61-43-48/23-62-50/53
S: 53-45-60-61
028-051-00-4
nickel diarsenide; [1]
nickel arsenide [2]
E, H
235-103-1 [1]
248-169-1 [2]
12068-61-0 [1]
27016-75-7 [2]
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-052-00-X
nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900
E, H
271-853-6
68610-24-2
Carc. Cat. 1: R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45
028-053-00-5
nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]
E, H
267-897-0 [1]
238-596-1 [2]
275-897-7 [3]
67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T: R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-054-00-0
nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(D-gluconato-O 1,O 2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C6-19-branched, nickel salts; [29]
fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]
E, H
240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]
16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]
Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53
T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61
C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-055-00-6
nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]
E, H
231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]
7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]
Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53
T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-056-00-1
nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]
E, H
234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]
12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]
Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53
T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-057-00-7
dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]
E, H
234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]
12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]
Carc. Cat. 1; R49
T; R48/23
R43
T
R: 49-43-48/23
S: 53-45
028-058-00-2
cobalt lithium nickel oxide
E
442-750-5
—
Carc. Cat. 1; R49
T+; R26
T; R48/23
R43
N; R50-53
T+; N
R: 49-26-43-48/23-50/53
S: 53-45-60-61
029-014-00-5
mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;
2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex
419-610-7
171866-24-3
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-51/53
S: (2-)22-36-61
030-012-00-1
aluminium-magnesium-zinc-carbonate-hydroxide
423-570-6
169314-88-9
R52-53
R: 52/53
S: 61
030-015-00-8
tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate
440-060-9
—
N; R51-53
N
R: 51/53
S: 61
042-005-00-0
mixture of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex
434-240-6
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61
050-023-00-5
mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
422-920-5
—
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)23-36-60-61
C ≥ 10 %: Xn, N; R48/22-50/53
2,5 % ≤ C < 10 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
050-024-00-0
mixture of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane
432-230-6
—
T; R48/25
Xn; R22
Xi; R38-41
R43
N; R50-53
T; N
R: 22-38-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61
064-001-00-8
gadolinium(III)sulfite trihydrate
456-900-2
51285-81-5
N; R51-53
N
R: 51/53
S: 61
078-011-00-5
hydroxydisulfito platinum(II) acid
423-310-1
61420-92-6
Xn; R22-48/20/21/22
C; R35
R42/43
R52-53
C
R: 22-35-42/43-48/20/21/22-52/53
S: (1/2-)23-24-26-28-36/37/39-45-61
078-012-00-0
platinum(IV) nitrate/nitric acid solution
432-400-1
—
C; R35
N; R50-53
C; N
R: 35-50/53
S: (1/2-)26-36/37/39-45-60-61
082-012-00-6
barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped
431-780-4
199876-46-5
Xn; R22-48/22
N; R51-53
Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61
601-080-00-5
mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers
431-100-6
—
N; R50-53
N
R: 50/53
S: 60-61
601-081-00-0
cyclohexadeca-1,9-diene
431-730-1
4277-06-9
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)36/37-61
601-082-00-6
mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane
434-420-4
—
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)23-26-37/39-57-60-61
601-083-00-1
5-endo-hexyl-bicyclo[2.2.1]hept-2-ene
435-000-3
22094-83-3
Xn; R65
Xi; R38
R53
Xn
R: 38-65-53
S: (2-)37-62-61
601-084-00-7
mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)
435-180-3
—
Xn; R65
Xi; R38
N; R50-53
Xn; N
R: 38-65-50/53
S: (2-)37-62-60-61
602-105-00-2
sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate
422-100-7
102061-82-5
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39
602-106-00-8
2-bromo-4,6-difluoroaniline
429-430-0
444-14-4
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)25-61
602-107-00-3
3,3,4,4-tetrafluoro-4-iodo-1-butene
439-500-2
33831-83-3
Xn; R22
Xi; R38
N; R51-53
Xn; N
R: 22-38-51/53
S: (2-)37-61
602-108-00-9
(2,3,5,6-tetrafluorophenyl)methanol
443-840-7
4084-38-2
Xn; R22
Xi; R36
R43
Xn
R: 22-36-43
S: (2-)26-36/37
603-211-00-1
2,3-epoxypropyltrimethylammonium chloride … %;
glycidyl trimethylammonium chloride … %
B E
221-221-0
3033-77-0
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
Xn; R21/22-48/22
Xi; R41
R43
R52-53
T
R: 45-21/22-41-43-48/22-62-68-52/53
S: 53-45-61
603-212-00-7
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide;
(HHCB)
214-946-9
1222-05-5
N; R50-53
N
R: 50/53
S: 60-61
603-213-00-2
2-methoxy-2-methylbutane;
tert-amyl methyl ether
213-611-4
994-05-8
F; R11
Xn; R22
R67
F; Xn
R: 11-22-67
S: (2-)9-16-23-33
603-214-00-8
1,1-diisopropoxycyclohexane
413-740-8
1132-95-2
C; R34
C
R: 34
S: (1/2-)23-26-36/37/39-45
603-215-00-3
1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)
418-330-2
162241-33-0
E; R2
Xn; R22-48/22
Xi; R41
R43
N; R50-53
E; Xn; N
R: 2-22-41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61
603-216-00-9
cis-1-amino-2,3-dihydro-1H-inden-2-ol
422-660-2
7480-35-5
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61
603-217-00-4
2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite
423-560-1
161717-32-4
R43
R53
Xi
R: 43-53
S: (2-)24-37/39-61
603-220-00-0
1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol
432-890-5
72955-94-3
R53
R: 53
S: 61
603-221-00-6
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]
433-580-2
214353-17-0
Xn; R22
C; R34
N; R51-53
C; N
R: 22-34-51/53
S: (1/2-)26-36/37/39-45-61
603-221-01-3
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]
E
433-580-2
214353-17-0
Carc. Cat. 2; R45
Xn; R22
C; R34
N; R51-53
T; N
R: 45-22-34-51/53
S: 53-45-61
603-222-00-1
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
433-820-6
118058-74-5
Xi; R36
Xi
R: 36
S: (2-)26
603-223-00-7
2-cyclopentylidene cyclopentanol;
1,1′-bi(cyclopentyliden)-2-ol
434-270-1
6261-30-9
Xi; R38-41
R52-53
Xi
R: 38-41-52/53
S: (2-)26-37/39-61
603-224-00-2
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane
435-790-1
297730-93-9
R53
R: 53
S: 61
603-225-00-8
erythromycin A9-oxime (E);
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)
437-070-0
13127-18-9
N; R51-53
N
R: 51/53
S: 61
603-226-00-3
4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol
444-500-0
1440-00-2
R52-53
R: 52/53
S: 61
603-227-00-9
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate
445-060-2
203574-04-3
O; R7
N; R50-53
O; N
R: 7-50/53
S: (2-)3/7-14-36/37/39-60-61
603-228-00-4
(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane
419-620-1
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)36/37-61
603-229-00-X
sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate
420-800-7
—
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61
603-230-00-5
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan
440-030-5
—
Xi; R38-41
R53
Xi
R: 38-41-53
S: (2-)26-37/39-61
603-231-00-0
(S)-1,1-diphenyl-1,2-propanediol
443-220-6
—
R52-53
R: 52/53
S: 22-61
603-232-00-6
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane
444-420-6
—
R53
R: 53
S: 61
603-233-00-1
mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol
444-430-0
—
N; R51-53
N
R: 51/53
S: 61
603-234-00-7
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene
444-480-3
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61
604-074-00-0
tetrabromobisphenol-A;
2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol
201-236-9
79-94-7
N; R50-53
N
R: 50/53
S: 60-61
604-075-00-6
4-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol
205-426-2
140-66-9
Xi; R38-41
N; R50-53
Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61
C ≥ 20 %: Xi, N; R38-41-50/53
10 % ≤ C < 20 %: Xi, N; R41-50/53
5 % ≤ C < 10 %: Xi, N; R36-50/53
2,5 % ≤ C < 5 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
604-076-00-1
phenolphthalein
201-004-7
77-09-8
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T
R: 45-62-68
S: 53-45
C ≥ 5 %: T; R45-62-68
1 % ≤ C < 5 %: T; R45-68
604-077-00-7
2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol
419-750-9
98809-58-6
R53
R: 53
S: 61
604-079-00-8
4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol
428-970-4
13595-25-0
Repr.Cat.3; R62
R43
N; R51-53
Xn; N
R: 43-62-51/53
S: (2-)22-36/37-61
604-080-00-3
4-fluoro-3-trifluoromethylphenol
432-560-0
61721-07-1
Xn; R20
C; R35
R43
N; R51-53
C; N
R: 20-35-43-51/53
S: (1/2-)26-28-36/37/39-45-61
604-081-00-9
1,1-bis(4-hydroxyphenyl)-1-phenylethane
433-130-5
1571-75-1
N; R50-53
N
R: 50/53
S: 25-60-61
604-082-00-4
2-chloro-6-fluoro-phenol
E
433-890-8
2040-90-6
Muta.Cat.2; R46
Repr.Cat.3; R62
Xn; R22
C; R34
R43
N; R51-53
T; N
R: 46-22-34-43-62-51/53
S: 53-45-61
604-083-00-X
4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol
439-270-3
260408-02-4
R53
R: 53
S: 61
604-084-00-5
1-ethoxy-2,3-difluorobenzene
441-000-4
121219-07-6
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)23-61
604-087-00-1
mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol
433-640-8
—
F; R17
R44
R53
F
R: 17-44-53
S: (2-)15-22-61
604-089-00-2
2-methyl-5-tert-butylthiophenol
444-970-7
—
R10
Repr.Cat.3; R63
Xn; R48/20/22-65
Xi; R36/38
R43
R67
N; R50-53
Xn; N
R: 10-36/38-43-48/20/22-63-65-67-50/53
S: (2-)26-36/37-62-60-61
605-037-00-1
trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde
421-800-1
120578-03-2
R53
R: 53
S: 22-61
605-038-00-7
3-methyl-5-phenylpentan-1-al
433-900-0
55066-49-4
Xn; R22
Xi; R38
R43
N; R51-53
Xn; N
R: 22-38-43-51/53
S: (2-)36/37-61
605-039-00-2
3,4-dihydroxy-5-nitrobenzaldehyde
441-810-8
116313-85-0
Xn; R22
Xi; R41
R43
Xn
R: 22-41-43
S: (2-)22-24-26-37/39
606-124-00-7
1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione
421-080-7
161462-35-7
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)36-60-61
606-125-00-2
1-benzylimidazolidine-2,4-dione
421-340-1
6777-05-5
Xn; R22
Xn
R: 22
S: (2-)22
606-126-00-8
1,4-bis(2,3-dihydroxypropylamino)anthraquinone
421-470-7
99788-75-7
N; R51-53
N
R: 51/53
S: 61
606-128-00-9
2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione
422-650-8
148935-94-8
R53
R: 53
S: 61
606-129-00-4
5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one
423-090-7
156732-13-7
R53
R: 53
S: 61
606-130-00-X
4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone
423-860-2
56309-94-5
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61
606-131-00-5
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
E
427-230-8
5571-36-8
Repr. Cat. 2; R60
Xn; R48/22
N; R51-53
T; N
R: 60-48/22-51/53
S: 53-45-61
606-132-00-0
(6β)-6,19-epoxyandrost-4-ene-3,17-dione
433-490-3
6563-83-3
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-61
606-134-00-1
androsta-1,4,9(11)-triene-3,17-dione
433-560-3
15375-21-0
Repr. Cat.3; R62
Xn
R: 62
S: (2-)22-36/37
606-135-00-7
cyclohexadecanone
438-930-8
2550-52-9
R53
R: 53
S: 61
606-136-00-2
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone
444-350-6
133413-70-4
Xi; R36
R53
Xi
R: 36-53
S: (2-)26-61
606-137-00-8
trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione
444-750-0
211387-26-7
R53
R: 53
S: 22-61
606-138-00-3
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone
444-800-1
141645-23-0
R10
Xn; R22-48/22
Xi; R38-41
R43
N; R50-53
Xn; N
R: 10-22-38-41-43-48/22-50/53
S: (2-)23-26-36/37/39-60-61
C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53
20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53
10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
606-139-00-9
(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one
444-830-5
124379-29-9
R53
R: 53
S: 61
606-140-00-4
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one
444-860-9
474510-57-1
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61
606-141-00-X
sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate
418-410-7
—
Xi; R36
Xi
R: 36
S: (2-)26
606-142-00-5
mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
434-290-9
—
Xn; R22
N; R51-53
Xn; N
R: 22-51/53
S: (2-)61
607-580-00-X
ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate
422-360-1
100491-29-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)22-24-37-61
607-618-00-5
menadione sodium bisulfite;
2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt
204-987-0
130-37-0
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61
607-619-00-0
menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)
277-543-7
73581-79-0
Xi; R36/38
N; R50-53
Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61
607-620-00-6
trisodium nitrilotriacetate
225-768-6
5064-31-3
Carc. Cat. 3; R40
Xn; R22
Xi; R36
Xn
R: 22-36-40
S: (2-)26-36/37-46
C ≥ 25 %: Xn; R22-36-40
20 ≤ % C < 25 %: Xn; R36-40
5 ≤ % C < 20 %: Xn; R40
607-621-00-1
milbemectin (ISO);
[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]
—
—
Xn; R20/22
N; R50-53
Xn; N
R: 20/22-50/53
S: (2-)46-60-61
C ≥ 25 %: Xn, N; R20/22-50/53
0,25 % ≤ C < 25 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53
607-622-00-7
2-ethylhexyl-2-ethylhexanoate
231-057-1
7425-14-1
Repr. Cat. 3; R63
Xn
R: 63
S: (2-)36/37
607-623-00-2
diisobutyl phthalate
201-553-2
84-69-5
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T
R: 61-62
S: 53-45
C ≥ 25 %: T; R61-62
5 % ≤ C < 25 %: Xn; R62
607-624-00-8
perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]
E
217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]
1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]
Carc. Cat. 3; R40
Repr. Cat. 2; R61
T; R48/25
Xn; R20/22
R64
N; R51-53
T; N
R: 61-20/22-40-48/25-64-51/53
S: 53-45-61
607-625-00-3
clodinafop-propargyl (ISO)
—
105512-06-9
Xn; R22-48/22
R43
N; R50-53.
Xn; N
R: 22-43-48/22-50/53
S: (2-)24-36/37-46-60-61
C ≥ 25 %: Xn, N; R22-43-48/22-50/53
10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53
2,5 % ≤ C < 10 %: Xi, N; R43-51/53
0,25 % ≤ C < 2,5 %: Xi; R43-52/53
0,001 % ≤ C < 0,25 %: Xi; R43
607-626-00-9
ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate
401-290-5
103112-35-2
Carc.Cat.2; R45
N; R50-53
T; N
R: 45-50/53
S: 53-45-60-61
607-627-00-4
[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate
416-360-0
162221-28-5
R43
Xi
R: 43
S: (2-)22-24-37
607-628-00-X
4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine
419-240-6
171054-89-0
Xi; R41
Xi
R: 41
S: (2-)26-39
607-629-00-5
[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid
419-270-1
123599-82-6
Xi; R36
Xi
R: 36
S: (2-)26
607-630-00-0
acrylic acid, 3-(trimethoxysilyl)propyl ester
419-560-6
4369-14-6
Xn; R20
C; R34
R43
R52-53
C
R: 20-34-43-52/53
S: (1/2-)26-36/37/39-45-61
607-631-00-6
mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate
442-300-8
—
R43
Xi
R: 43
S: (2-)24-37
607-632-00-1
N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide
420-210-1
111244-14-5
R53
R: 53
S: 61
607-633-00-7
trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate
440-480-2
341026-59-3
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39
607-634-00-2
(S)-(-)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-oxoethyl acetate
420-610-4
36394-75-9
Xn; R22
C; R34
R43
C
R: 22-34-43
S: (1/2-)23-26-36/37/39-45
607-635-00-8
trisodium N-(3-propionato)-L-aspartate
422-090-4
172737-80-3
Xi; R41
Xi
R: 41
S: (2-)26-39
607-636-00-3
1-bromo-2-methylpropyl propionate
422-900-6
158894-67-8
R10
Carc.Cat.3; R40
C; R34
R43
C
R: 10-34-40-43
S: (1/2-)7/9-8-23-26-36/37/39-45
607-637-00-9
disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate
423-730-5
250688-43-8
Xi; R41
Xi
R: 41
S: (2-)26-39
607-638-00-4
2-hydroxybenzoic acid 2-butyloctyl ester
431-090-3
190085-41-7
R53
R: 53
S: 61
607-639-00-X
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate
431-770-1
216698-07-6
R53
R: 53
S: 61
607-641-00-0
2-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid
431-930-9
43028-69-9
Xn; R22
R43
Xn
R: 22-43
S: (2-)22-24-37
607-642-00-6
3,6,9-trithiaundecamethylene-1,11-dimethacrylate
432-210-7
141631-22-3
N; R50-53
N
R: 50/53
S: 60-61
607-643-00-1
dimethyl (2S)-2-hydroxysuccinate
432-310-0
617-55-0
R10
Xi; R41
R43
Xi
R: 10-41-43
S: (2-)24-26-37/39-43
607-644-00-7
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate
432-350-9
81752-87-6
Xi; R38
Xi
R: 38
S: (2-)37
607-645-00-2
tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate
432-550-6
243858-01-7
Xi; R41
Xi
R: 41
S: (2-)22-26-39
607-646-00-8
D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;
tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
432-960-5
124655-09-0
Xn; R22
Xn
R: 22
S: (2-)25
607-647-00-3
5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane
433-530-1
143446-73-5
Xn; R22
R43
N; R50
Xn; N
R: 22-43-50
S: (2-)24-37-57-61
607-649-00-4
[3-(chlorocarbonyl)-2-methylphenyl]acetate
433-690-0
167678-46-8
C; R35
R43
C
R: 35-43
S: (1/2-)7/8-26-36/37/39-45
607-650-00-X
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate
433-910-5
145153-52-2
R43
Xi
R: 43
S: (2-)24-37
607-651-00-5
sodium 2-(nonanoyloxy)benzenesulfonate
434-360-9
91125-43-8
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39
607-652-00-0
ethyl N 2-dodecanoyl-L-argininate hydrochloride
434-630-6
60372-77-2
Xi; R41
N; R50
Xi; N
R: 41-50
S: (2-)26-39-61
607-653-00-6
tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate
434-840-8
225786-91-4
N; R51-53
N
R: 51/53
S: 61
607-654-00-1
(S)-3-hydroxy-γ-butyrolactone
434-990-4
7331-52-4
R43
Xi
R: 43
S: (2-)23-24-37
607-655-00-7
ethyl 6,8-dichlorooctanoate
435-080-1
1070-64-0
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61
607-656-00-2
sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid
435-350-7
141250-43-3
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61
607-657-00-8
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate
436-920-8
172399-10-9
Xi; R41
Xi
R: 41
S: (2-)22-26-39
607-658-00-3
3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt
440-770-9
371921-63-0
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61
607-659-00-9
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid
442-030-0
321912-47-4
Xi; R41
Xi
R: 41
S: (2-)22-26-39
607-660-00-4
2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt
442-230-8
321679-52-1
Xi; R41
Xi
R: 41
S: (2-)22-26-39
607-661-00-X
1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate
442-850-9
114772-40-6
R43
R53
Xi
R: 43-53
S: (2-)22-24-37-61
607-662-00-5
methyl 2-(acetylamino)-3-chloropropionate
442-860-3
87333-22-0
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-60-61
607-663-00-0
bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate
442-980-6
127474-91-3
R53
R: 53
S: 61
607-664-00-6
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate
443-120-2
393509-79-0
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)26-39-61
607-665-00-1
trans-methyl-2-ethyl-but-2-enoate
443-150-6
101226-85-1
R10
R: 10
S: 23
607-666-00-7
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid
443-560-5
88784-33-2
Xi; R36
Xi
R: 36
S: (2-)26
607-667-00-2
chloro-1-ethylcyclohexyl carbonate
444-950-8
99464-83-2
Muta.Cat.3; R68
R43
Xn
R: 43-68
S: (2-)23-36/37
607-668-00-8
trans-2-isopropyl-5-carboxy-1,3-dioxane
445-770-2
42031-28-7
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61
607-669-00-3
methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate
445-990-9
376588-17-9
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
607-670-00-9
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate
448-700-9
500791-70-8
Xn; R48/22
Xi; R41
R43
N; R50-53
Xn; N
R: 41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61
C ≥ 10 %: Xn, N; R41-43-48/22-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
607-671-00-4
diethyl 1,4-cyclohexanedicarboxylate
417-310-0
72903-27-6
N; R51-53
N
R: 51/53
S: 61
607-672-00-X
mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate
419-000-0
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61
607-673-00-5
1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate
419-570-0
—
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)61
607-674-00-0
branched C10-alkyl benzoates
421-090-1
131298-44-7
Xn; R20
Xn
R: 20
S: (2-)23
607-675-00-6
mixture of: cis-9-octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid
422-260-8
—
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61
607-676-00-1
mixture of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid
423-670-1
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39
607-677-00-7
2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate
424-660-8
—
Xn; R48/22
Xi; R41
R43
Xn
R: 41-43-48/22
S: (2-)22-26-36/37/39
607-678-00-2
mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate
427-090-8
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)23-25-36/37-61
607-679-00-8
mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)
431-440-5
—
Xi; R41
N; R51-53
Xi; N
R: 41-51/53
S: (2-)22-26-39-61
607-680-00-3
tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate
432-810-9
—
R53
R: 53
S: 61
607-681-00-9
mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate
432-910-2
—
R53
R: 53
S: 61
607-682-00-4
complex mixture of Chinese gum rosin post reacted with acrylic acid
434-230-1
144413-22-9
R53
R: 53
S: 61
607-683-00-X
mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)
435-450-0
—
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61
607-684-00-5
alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts
435-660-2
243662-67-1
Xi; R38
R43
Xi
R: 38-43
S: (2-)24-37
607-685-00-0
ammonium 2-cocoyloxyethanesulfonate
441-050-7
—
Xi; R38-41
Xi
R: 38-41
S: (2-)26-37/39
607-686-00-6
6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)
441-550-5
—
E; R2
F; R11
Carc. Cat. 3; R40
E; Xn
R: 2-11-40
S: (2-)7-22-36/37
607-687-00-1
mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)
442-800-6
—
Xi; R38
N; R51-53
Xi; N
R: 38-51/53
S: (2-)37-61
607-688-00-7
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride
444-320-2
—
Xn; R22
Xn
R: 22
S: (2-)
607-689-00-2
mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);
methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)
444-920-4
—
R52-53
R: 52/53
S: 61
607-690-00-8
dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate
432-860-1
255387-46-3
R43
Xi
R: 43
S: (2-)24-37
607-691-00-3
magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
448-690-6
—
R53
R: 53
S: 61
607-692-00-9
zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear
446-470-4
—
R53
R: 53
S: 61
607-693-00-4
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate
443-860-6
302776-68-7
R53
R: 53
S: 61
607-694-00-X
ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate
443-870-0
163520-33-0
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)22-36/37-60-61
608-042-00-7
(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide
421-810-4
194602-27-2
Xn; R22
Xi; R41
R43
N; R51-53
Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61
608-059-00-X
5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile
421-240-6
120068-79-3
N; R51-53
N
R: 51/53
S: 22-61
608-060-00-5
5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile
421-300-1
138564-59-7
N; R50-53
N
R: 50/53
S: 22-60-61
608-062-00-6
2-fluoro-4-hydroxybenzonitrile
422-810-7
82380-18-5
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61
608-063-00-1
(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile
441-070-6
61826-76-4
T; R25
Xi; R41
R43
N; R50-53
T; N
R: 25-41-43-50/53
S: (1/2-)9-26-36/37/39-45-60-61
608-064-00-7
cyanomethyltrimethylammoniummethylsulfate
433-720-2
—
R52-53
R: 52/53
S: 61
609-069-00-7
musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone
201-328-9
81-14-1
Carc. Cat. 3; R40
N; R50-53
Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61
611-154-00-9
trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate
403-670-6
92408-46-3
R52-53
R: 52/53
S: 61
611-155-00-4
4,4′-oxybis(benzenesulfonylazide)
431-850-4
7456-68-0
E; R3
F; R11
Xn; R48/22
N; R50-53
E; Xn; N
R: 3-11-48/22-50/53
S: (2-)14-22-33-35-36-60-61
611-156-00-X
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate
432-270-4
221354-37-6
Repr. Cat. 3; R62
Xn; R48/22
N; R51-53
Xn; N
R: 48/22-62-51/53
S: (2-)36/37-61
611-157-00-5
benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate
432-590-4
243869-48-9
Xi; R36
R52-53
Xi
R: 36-52/53
S: (2-)26-61
611-158-00-0
reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride
421-520-8
—
F; R11
R53
F
R: 11-53
S: (2-)3-12-16-33-61
611-159-00-6
disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate
421-880-6
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61
611-160-00-1
mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;
1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)
422-760-6
—
F; R11
R53
F
R: 11-53
S: (2-)3-12-33-61
611-161-00-7
trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)
423-100-1
—
Xi; R41
Xi
R: 41
S: (2-)26-39
611-162-00-2
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)
429-600-4
—
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61
611-163-00-8
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate
429-610-9
—
Xn; R22
Xi; R41
N; R51-53
Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61
611-164-00-3
mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;
2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);
2,2′-dimethyl-2,2′-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)
429-710-2
—
R10
R32
R44
Xn; R22
N; R51-53
Xn; N
R: 10-22-32-44-51/53
S: (2-)12-15-16-47-51-61
611-165-00-9
mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
431-830-5
—
R52-53
R: 52/53
S: 61
611-166-00-4
mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
432-100-9
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)26-39-61
611-167-00-X
sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)
435-240-9
—
R52-53
R: 52/53
S: 61
611-168-00-5
mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid
435-440-6
—
Xi; R41
Xi
R: 41
S: (2-)22-26-39
611-169-00-0
sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate
435-800-2
—
R52-53
R: 52/53
S: 61
611-170-00-6
mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)
435-880-9
—
R52-53
R: 52/53
S: 22-61
611-171-00-1
mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate
436-890-6
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61
611-172-00-7
mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate
438-310-7
—
E; R2
Repr. Cat. 3; R62
Xn; R22-48/22
R52-53
E; Xn
R: 2-22-48/22-62-52/53
S: (2-)22-35-36/37-61
611-173-00-2
mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt
440-510-4
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-26-36/37/39
611-174-00-8
mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt
442-290-5
457624-86-1
Xi; R41
Xi
R: 41
S: (2-)22-26-39
611-175-00-3
mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate
444-050-5
—
Xi; R41
R52-53
Xi
R: 41-52/53
S: (2-)22-26-39-61
611-176-00-9
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate
444-250-2
—
E; R2
F; R11
N; R51-53
E; N
R: 2-11-51/53
S: (2-)22-61
611-177-00-4
mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)
444-290-0
508202-43-5
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61
611-178-00-X
mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate
445-280-9
—
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61
611-179-00-5
mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate
450-010-8
—
Xi; R41
R43
Xi
R: 41-43
S: (2-)22-24-26-37/39
611-180-00-0
iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts
417-850-7
—
N; R51-53
N
R: 51/53
S: 22-61
612-238-00-8
(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %
B
222-048-3
3327-22-8
Carc. Cat. 3, R40
R52-53
Xn
R: 40-52/53
S: 36/37-61
612-239-00-3
biphenyl-3,3′,4,4′-tetrayltetraamine;
diaminobenzidine
202-110-6
91-95-2
Carc. Cat. 2; R45
Muta. Cat. 3; R68
T
R: 45-68
S: 53-45
612-240-00-9
pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)aniline
—
53112-28-0
N; R51-53
N
R: 51/53
S: 61
612-241-00-4
piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]
228-042-7 [1]
205-551-2 [2]
217-775-8 [3]
6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]
Repr. Cat. 3; R62-63
Xi; R36/38
R42/43
R52-53
Xn
R: 36/38-42/43-62-63-52/53
S: (1/2-)22-36/37-45-63-61
612-242-00-X
cyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
—
121552-61-2
R43
N; R50-53
Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61
C ≥ 2,5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-243-00-5
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate
420-560-3
79617-97-3
Xi; R41
N; R50-53
Xi; N
R: 41-50/53
S: (2-)26-39-60-61
C ≥ 10 %: Xi, N; R41-50/53
5 % ≤ C < 10 %: Xi, N; R36-50/53
2,5 % ≤ C < 5 %: N; R50/53
0,25 % ≤ C < 2, 5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-244-00-0
3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride
421-310-6
87691-88-1
Repr. Cat. 3; R62
Xn; R22
Xi; R36
R43
N; R50-53
Xn; N
R: 22-36-43-62-50/53
S: (2-)22-26-36/37/39-60-61
612-245-00-6
2-ethylphenylhydrazine hydrochloride
421-460-2
19398-06-2
Carc. Cat. 3; R40
T; R48/25
Xn; R22
Xi; R41
R43
N; R50-53
T; N
R: 22-40-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61
C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53
10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53
5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53
2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-246-00-1
(2-chloroethyl)(3-hydroxypropyl)ammonium chloride
E
429-740-6
40722-80-3
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/22
R43
R52-53
T
R: 45-46-43-48/22-52/53
S: 53-45-61
612-247-00-7
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide
423-530-8
152828-23-4
T; R48/25
Xn; R22
R52-53
T
R: 22-48/25-52/53
S: (1/2-)22-36-45-61
612-248-00-2
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)
439-540-0
—
Xi; R38
R43
R53
Xi
R: 38-43-53
S: (2-)24-37-61
612-249-00-8
4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride
425-030-5
159939-85-2
Repr. Cat. 3; R62
Xn; R22
C; R34
R43
N; R51-53
C; N
R: 22-34-43-62-51/53
S: (1/2-)22-26-36/37/39-45-61
612-250-00-3
chloro-N,N-dimethylformiminium chloride
E
425-970-6
3724-43-4
R14
Repr. Cat. 2; R61
Xn; R22
C; R35
T; C
R: 61-14-22-35
S: 53-45
612-251-00-9
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
426-020-3
51229-78-8
F; R11
Repr. Cat. 3; R63
Xn; R22
Xi; R38
R43
N; R51-53
F; Xn; N
R: 11-22-38-43-63-51/53
S: (2-)7-22-33-36/37-61
612-252-00-4
imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine
428-040-8
138261-41-3
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)22-57-60-61
612-253-00-X
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
R52-53
R: R52/53
S: 61
612-253-01-7
7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing ≥ 0,5 % formamide (EC No 200-842-0)]
429-400-7
199327-61-2
Repr. Cat. 2; R61
R52-53
T
R: 61-52/53
S: 53-45-61
612-254-00-5
reaction products of diisopropanolamine with formaldehyde (1:4)
432-440-8
220444-73-5
Carc. Cat. 3; R40
Xn; R22
C; R34
R43
N; R51-53
C; N
R: 22-34-40-43-51/53
S: (1/2-)13-25-26-36/37/39-45-61
612-255-00-0
1-(3-methoxypropyl)-4-piperidinamine
431-950-8
179474-79-4
Xn; R21/22
C; R34
R52-53
C
R: 21/22-34-52/53
S: (1/2-)26-36/37/39-45-61
612-256-00-6
benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate
427-470-3
137864-22-3
Xn; R22
R43
Xn
R: 22-43
S: (2-)36/37
612-257-00-1
tripropylammonium dihydrogenphosphate
433-700-3
35687-90-2
Xn; R22
Xn
R: 22
S: (2-)22
612-259-00-2
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine
437-720-3
227085-51-0
Xi; R41
Xi
R: 41
S: (2-)26-39
612-261-00-3
3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline
441-190-9
121451-05-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61
C ≥ 25 %: Xn, N; R22-43-50/53
2,5 % ≤ C < 25 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-265-00-5
bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate
444-360-0
191617-13-7
R52-53
R: 52/53
S: 61
612-266-00-0
3-chloro-4-(3-fluorobenzyloxy)aniline
445-590-4
202197-26-0
Muta. Cat. 3; R68
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-68-50/53
S: (2-)22-36/37-60-61
612-267-00-6
bis(hydrogenated tallow C16-18-alkyl)hydroxylamine
418-370-0
—
R43
R53
Xi
R: 43-53
S: (2-)36/37-61
612-269-00-7
mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline
420-720-2
—
R53
R: 53
S: 22-61
612-270-00-2
(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride
433-010-2
—
Xn; R22
R43
R52-53
Xn
R: 22-43-52/53
S: (2-)22-36/37-61
612-271-00-8
mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate
434-970-5
160987-57-5
R53
R: 53
S: 61
612-272-00-3
ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate
435-210-5
—
N; R51-53
N
R: 51/53
S: 61
612-273-00-9
alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride
435-650-8
—
Xn; R22
C; R35
N; R50-53
C; N
R: 22-35-50/53
S: (1/2-)26-36/37/39-45-60-61
612-274-00-4
(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate
445-750-3
—
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)22-24-26-37/39-61
612-275-00-X
fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil
447-880-6
206565-89-1
Xi; R38-41
R43
N; R50-53
Xi; N
R: 38-41-43-50/53
S: (2-)23-26-36/37/39-60-61
C ≥ 20 %: Xi, N; R38-41-43-50/53
10 % ≤ C < 20 %: Xi, N; R41-43-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-276-00-5
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts
451-430-4
500717-36-2
Xi; R41
R43
R52-53
Xi
R: 41-43-52/53
S: (2-)22-24-26-36/37/39-61
612-277-00-0
mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium
451-440-9
586372-44-3
Xi; R41
Xi
R: 41
S: (2-)22-26-39
612-278-00-6
ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide
214-984-6
1239-45-8
Muta. Cat. 3; R68
T+; R26
Xn; R22
T+
R: 22-26-68
S: (1/2-)28-36/37-45-63
612-279-00-1
(R,S)-2-amino-3,3-dimethylbutane amide
447-860-7
144177-62-8
Repr. Cat. 3; R62
Xn; R48/22
Xi; R36/38
R43
Xn
R: 36/38-43-48/22-62
S: (2-)22-26-36/37
612-280-00-7
3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine
H
205-057-7
132-32-1
Carc. Cat. 2; R45
T
R: 45
S: 53-45
613-116-01-4
tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]
211-986-9
731-27-1
Xi; R36/37/38
R43
N; R50
Xi; N
R: 36/37/38-43-50
S: (2-)25-36/37-46-61
C ≥ 20 %: Xi, N; R36/37/38-43-50
2,5 % ≤ C < 20 %: Xi, N; R43-50
1 % ≤ C < 2,5 %: Xi; R43
613-280-00-X
tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea
230-625-6
7226-23-5
Repr. Cat. 3; R62
Xn; R22
Xi; R41
Xn
R: 22-41-62
S: 26-36/37/39
613-281-00-5
quinoline
E
202-051-6
91-22-5
Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R21/22
Xi; R36/38
N; R51-53
T; N
R: 45-21/22-36/38-68-51/53
S: 53-45-61
613-282-00-0
triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol
—
131983-72-7
N; R51-53
N
R: 51/53
S: 61
613-283-00-6
ketoconazole;
1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
E
265-667-4
65277-42-1
Repr. Cat. 2; R60
T; R25
Xn; R48/22
N; R50-53
T; N
R: 60-25-48/22-50/53
S: 53-45-60-61
613-284-00-1
metconazole (ISO);
(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
—
125116-23-6
Repr. Cat. 3; R63
Xn; R22
N; R51-53
Xn; N
R: 22-63-51/53
S: (2-)36/37-46-61
613-285-00-7
1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]
219-989-7 [1]
219-989-7 [2]
2592-95-2 [1]
123333-53-9 [2]
E; R2
E
R: 2
S: 16-35
613-286-00-2
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]
418-260-2
183196-57-8
R43
Xi
R: 43
S: (2-)24-37
613-286-01-X
potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]
418-260-2
183196-57-8
Repr. Cat. 2; R61
R43
T
R: 61-43
S: 53-45
613-287-00-8
1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole
419-540-7
160194-26-3
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61
613-288-00-3
1,3-bis(dimethylcarbamoyl)-imidazolium chloride
420-930-4
135756-61-5
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-37/39-61
613-289-00-9
3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole
432-020-4
142623-48-1
N; R50-53
N
R: 50/53
S: 60-61
613-290-00-4
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride
432-470-1
189012-93-9
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61
613-291-00-X
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one
434-820-9
106461-41-0
Xn; R48/22
N; R50-53
Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61
613-292-00-5
N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine
435-010-8
26157-73-3
Muta. Cat. 3; R68
R52-53
Xn
R: 68-52/53
S: (2-)36/37-61
613-293-00-0
2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester
448-050-6
444065-11-6
R53
R: 53
S: 61
613-294-00-6
2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester
448-260-8
379268-96-9
R53
R: 53
S: 61
613-295-00-1
11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride
448-720-8
363138-44-7
Xn; R22
Xi; R41
R52-53
Xn
R: 22-41-52/53
S: (2-)22-26-39-61
613-296-00-7
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate
418-270-7
—
R43
R52-53
Xi
R: 43-52/53
S: (2-)24-37-47-61
613-297-00-2
5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole
420-820-6
—
R10
Xn; R22
N; R51-53
Xn; N
R: 10-22-51/53
S: (2-)16-61
613-298-00-8
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate
421-560-6
—
Xn; R48/22
Xi; R41
N; R51-53
Xn; N
R: 41-48/22-51/53
S: (2-)22-26-36/39-61
613-299-00-3
main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt
422-610-1
—
Xi; R41
Xi
R: 41
S: (2-)22-26-39
613-300-00-7
1-imidazol-1-yl-octadecan-2-ol
434-120-3
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
613-301-00-2
dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate
443-910-7
—
R53
R: 53
S: 61
613-302-00-8
disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate
432-980-4
243858-60-8
Xi; R41
Xi
R: 41
S: (2-)22-26-39
613-303-00-3
2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine
429-800-1
95737-68-1
N; R50-53
N
R: 50/53
S: 60-61
613-304-00-9
5,6-dihydroxy-2,3-dihydro-1H-indolium bromide
421-170-6
138937-28-7
Xn; R22
Xi; R41
Xn
R: 22-41
S: (2-)22-26-39
613-305-00-4
2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole
448-630-9
3147-77-1
R53
R: 53
S: 61
613-306-00-X
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate
433-520-5
82911-69-1
Xn; R22
R43
N; R51-53
Xn; N
R: 22-43-51/53
S: (2-)24-37-61
613-307-00-5
clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine
—
210880-92-5
Xn; R22
N; R50-53
Xn; N
R: 22-50/53
S: (2-)46-60-61
C ≥ 25 %: Xn, N; R22-50/53
2,5 % ≤ C < 25 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
613-308-00-0
2-amino-5-methylthiazole
423-800-5
7305-71-7
Xn; R22-48/22
N; R50-53
Xn; N
R: 22-48/22-50/53
S: (2-)22-36-60-61
613-309-00-6
1-methyl-3-phenyl-1-piperazine
431-180-2
5271-27-2
Xn; R21/22
Xi; R38-41
R52-53
Xn
R: 21/22-38-41-52/53
S: (2-)26-36/37/39-61
613-310-00-1
(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride
432-360-3
105813-13-6
Xn; R22
R43
N; R50-53
Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61
613-311-00-7
methyl-5-nitrophenyl-guanidine
435-500-1
152460-07-6
Xn; R22
Xi; R36
R43
R52-53
Xn
R: 22-36-43-52/53
S: (2-)22-24-26-37-61
613-312-00-2
2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride
420-200-5
—
Xn; R22
Xi; R41
R43
R52-53
Xn
R: 22-41-43-52/53
S: (2-)22-26-36/37/39-61
613-313-00-8
2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione
442-780-9
173838-67-0
R52-53
R: 52/53
S: 61
613-314-00-3
4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one
443-770-7
7693-82-5
N; R50-53
N
R: 50/53
S: 22-24-60-61
613-315-00-9
tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate
430-390-1
—
Xn; R20
R52-53
Xn
R: 20-52/53
S: (2-)25-61
613-316-00-4
trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)
H
257-765-0
52234-82-9
Muta. Cat. 3; R68
Xi; R41
R43
Xn
R: 41-43-68
S: 26-36/37/39-42
615-044-00-1
4-chlorophenylisocyanate
203-176-9
104-12-1
T+; R26
Xn; R22
Xi; R37/38-41
R42
N; R50-53
T+; N
R: 22-26-37/38-41-42-50/53
S: (1/2-)26-28-36/37/39-45-63-60-61
615-045-00-7
4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)
420-530-1
—
R42/43
R53
Xn
R: 42/43-53
S: (2-)23-24-37-45-61
616-126-00-X
1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide
423-960-6
139756-01-7
Xn; R22-48/22
R52-53
Xn
R: 22-48/22-52/53
S: (2-)22-36/37-61
616-164-00-7
dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
—
149961-52-4
Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R20
N; R50-53
Xn; N
R: 20-40-63-50/53
S: (2-)36/37-46-60-61
C ≥ 25 %: Xn, N; R20-40-63-50/53
5 % ≤ C < 25 %: Xn, N; R40-63-50/53
2,5 % ≤ C < 5 %: Xn, N; R40-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52-53
616-165-00-2
beflubutamid (ISO);
(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide
—
113614-08-7
N; R50-53
N
R: 50/53
S: 60-61
C ≥ 0,25 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53
616-166-00-8
cyazofamid (ISO);
4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide
—
120116-88-3
N; R50-53
N
R: 50/53
S: 60-61
C ≥ 2,5 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51-53
0,025 % ≤ C < 0,25 %: R52/53
616-167-00-3
N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide
418-290-6
168612-06-4
Xi; R36
R43
Xi
R: 36-43
S: (2-)24-26-37
616-168-00-9
1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium
418-440-0
136997-71-2
R43
Xi
R: 43
S: (2-)22-24-37
616-169-00-4
4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one
420-220-4
92771-56-7
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
616-170-00-X
(2R)-2-amino-2-phenylacetamide
420-370-0
6485-67-2
Xi; R36
R43
Xi
R: 36-43
S: (2-)22-26-36/37
616-171-00-5
2-(para-chlorophenyl)glycineamide
420-830-0
102333-75-5
Xi; R41
R43
Xi
R: 41-43
S: (2-)24-26-37/39
616-172-00-0
N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl
423-840-3
14691-89-5
Xn; R22
Xn
R: 22
S: (2-)22
616-174-00-1
2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride
424-560-4
151257-01-1
Xn; R22
Xi; R36
Xn
R: 22-36
S: (2-)22-26
616-175-00-7
2-(2-hexyldecyloxy)benzamide
431-230-3
202483-62-3
R53
R: 53
S: 61
616-176-00-2
3-N,N-bis(methoxyethyl)aminoacetanilide
432-530-7
24294-01-7
Xn; R22
R52-53
Xn
R: 22-52/53
S: (2-)22-24-61
616-177-00-8
(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide
432-970-1
217324-98-6
R53
R: 53
S: 61
616-178-00-3
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide
434-500-9
52583-35-4
R53
R: 53
S: 22-61
616-179-00-9
2-chloro-N-(4-methylphenyl)acetamide
435-170-9
16634-82-5
Xi; R41
R43
N; R50-53
Xi; N
R: 41-43-50/53
S: (2-)22-26-36/37/39-60-61
616-180-00-4
N,N-(dimethylamino)thioacetamide hydrochloride
435-470-1
27366-72-9
Repr. Cat. 2; R61
N; R50-53
T; N
R: 61-50/53
S: 53-45-60-61
616-181-00-X
4′-methyldodecane-1-sulfonanilide
435-490-9
17417-32-2
N; R50-53
N
R: 50/53
S: 60-61
616-182-00-5
N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide
435-860-1
214417-91-1
R43
N; R51-53
Xi; N
R: 43-51/53
S: (2-)24-37-61
616-183-00-0
N-dodecyl-4-methoxybenzamide
442-340-6
1854-15-5
R53
R: 53
S: 61
616-184-00-6
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide
442-560-2
105043-55-8
R53
R: 53
S: 61
616-186-00-7
N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)
443-010-4
53641-10-4
R52-53
R: 52/53
S: 61
616-188-00-8
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide
443-980-9
221215-20-9
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
616-189-00-3
N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide
444-780-4
452962-97-9
R53
R: 53
S: 61
616-190-00-9
N-decyl-4-nitrobenzamide
445-880-0
64026-19-3
R53
R: 53
S: 61
616-191-00-4
2-ethyl-N-methyl-N-(3-methylphenyl)butanamide
446-190-2
406488-30-0
Xn; R22
Xi; R36/38
R43
N; R51-53
Xn; N
R: 22-36/38-43-51/53
S: (2-)24-26-37-61
616-192-00-X
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide
448-060-0
727678-39-9
R53
R: 53
S: 61
616-193-00-5
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide
449-940-7
368450-39-9
R53
R: 53
S: 61
616-194-00-0
2,2-diethoxy-N,N-dimethylacetamide
449-950-1
34640-92-1
Xi; R36
Xi
R: 36
S: (2-)26
616-196-00-1
disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide
419-990-4
—
N; R50-53
N
R: 50/53
S: 60-61
616-197-00-7
mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide
422-500-1
—
Xn; R48/22
Xn
R: 48/22
S: (2-)22-36
616-198-00-2
1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene
423-300-7
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
616-200-00-1
mixture of: N,N′-ethane-1,2-diylbis(hexanamide);
12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)
432-430-3
—
R43
R53
Xi
R: 43-53
S: (2-)24-37-61
616-201-00-7
12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine
432-840-2
220926-97-6
Xn; R20
R53
Xn
R: 20-53
S: (2-)22-61
616-202-00-2
mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide
434-330-5
—
Carc. Cat. 3; R40
R43
R53
Xn
R: 40-43-53
S: (2-)36/37-61
616-203-00-8
mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide
442-280-0
—
R53
R: 53
S: 61
616-204-00-3
N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]
451-060-3
122886-55-9
R53
R: 53
S: 61
617-022-00-7
mixture of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate
442-480-8
—
O; R7
Xn; R22
C; R34
R43
N; R51-53
O; C; N
R: 7-22-34-43-51/53
S: (1/2-)3/7-14-26-36/37/39-45-50-61
647-017-00-5
laccase
420-150-4
80498-15-3
R42
Xn
R: 42
S: (2-)23-45
ANNEX 1C
The entries in Annex I with the following Index numbers are deleted:
024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.
© European Union,
https://eur-lex.europa.eu, 1998 - 2025
